Abbott Laboratories (HAM:ABL) Cyclically Adjusted Book per Share: €21.64 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:ABL Abbott Laboratories HAM:ABL
80 GF Score
Price €91.14
GF Value €116.83
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott Laboratories Cyclically Adjusted Book per Share?

Abbott Laboratories HAM:ABL -5.10% 80 Cyclically Adjusted Book per Share is €21.64 as of Jun. 2026. GuruFocus rates HAM:ABL with a GF Score™ of 80/100 and a GF Value™ of €116.83 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Abbott Laboratories's adjusted book value per share for the three months ended in Jun. 2026 was €25.638. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €21.64 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Abbott Laboratories's average Cyclically Adjusted Book Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Abbott Laboratories was 14.20% per year. The lowest was 3.30% per year. And the median was 8.60% per year.

As of today (2026-07-31), Abbott Laboratories's current stock price is €91.14. Abbott Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €21.64. Abbott Laboratories's Cyclically Adjusted PB Ratio of today is 4.21.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Abbott Laboratories was 7.55. The lowest was 2.54. And the median was 5.11.


Abbott Laboratories  (HAM:ABL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Abbott Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=91.14/21.64
=4.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Abbott Laboratories was 7.55. The lowest was 2.54. And the median was 5.11.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Abbott Laboratories Cyclically Adjusted Book per Share Related Terms


Abbott Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Cyclically Adjusted Book per Share Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.58 18.69 18.64 21.13 19.57

Abbott Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.19 19.50 19.57 20.62 21.64

HAM:ABL vs SYK, MDT, BSX: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted PB Ratio falls into.


HAM:ABL
80GF Score
Abbott Laboratories HAM:ABL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=25.638/333.9520*333.9520
=25.638

Current CPI (Jun. 2026) = 333.9520.

Abbott Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201609 12.573 241.428 17.391
201612 13.219 241.432 18.285
201703 16.898 243.801 23.146
201706 16.188 244.955 22.069
201709 15.440 246.819 20.891
201712 14.974 246.524 20.284
201803 14.525 249.554 19.437
201806 14.920 251.989 19.773
201809 14.982 252.439 19.820
201812 15.283 251.233 20.315
201903 15.514 254.202 20.381
201906 15.866 256.143 20.686
201909 16.336 256.759 21.247
201912 15.875 256.974 20.630
202003 15.461 258.115 20.004
202006 15.336 257.797 19.866
202009 15.035 260.280 19.291
202012 15.215 260.474 19.507
202103 15.867 264.877 20.005
202106 15.825 271.696 19.451
202109 16.546 274.310 20.144
202112 17.961 278.802 21.514
202203 18.357 287.504 21.323
202206 19.712 296.311 22.216
202209 20.665 296.808 23.251
202212 19.928 296.797 22.423
202303 19.878 301.836 21.993
202306 19.772 305.109 21.641
202309 20.230 307.789 21.950
202312 20.414 306.746 22.225
202403 20.525 312.332 21.946
202406 20.993 314.175 22.314
202409 20.673 315.301 21.896
202412 26.286 315.605 27.814
202503 25.951 319.799 27.099
202506 25.189 322.561 26.079
202509 24.966 324.800 25.669
202512 25.636 324.054 26.419
202603 25.854 330.213 26.147
202606 25.638 333.952 25.638

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €21.64 mean?
Abbott Laboratories (HAM:ABL) has a Cyclically Adjusted Book per Share of €21.64 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Cyclically Adjusted Book per Share too high?
Abbott Laboratories' current Cyclically Adjusted Book per Share is €21.64. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Cyclically Adjusted Book per Share compare to SYK and MDT?
Abbott Laboratories' Cyclically Adjusted Book per Share of €21.64 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Cyclically Adjusted Book per Share is €21.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (HAM:ABL) is currently considered Modestly Undervalued. The stock's GF Value™ is €116.83, compared to a current price of €91.14 — trading 22% below its estimated fair value. The current Cyclically Adjusted Book per Share is €21.64. Abbott Laboratories' overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Abbott Laboratories (HAM:ABL), the current Cyclically Adjusted Book per Share is €21.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (HAM:ABL) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of €91.14 is trading 22% below its estimated GF Value™ of €116.83. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for HAM:ABL:

  • Cyclically Adjusted Book per Share: €21.64
  • GF Value™: €116.83 vs. price of €91.14 (22% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the HAM:ABL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for HAM:ABL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€91.14
Price
€116.83
GF Value